Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Judson

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
Clinical Sarcoma Research|March 27, 2015
Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden HospitalEirini Thanopoulou, Aleksandar Aleksic, Khin Thway, et al.
Molecular Cancer Therapeutics|April 1, 2008
BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitorsUdai Banerji, Annette Affolter, Ian Judson, et al.
BMJ Supportive & Palliative Care|December 31, 2015
'<i>When something is this rare … how do you know bad really is bad…?</i>'-views on prognostic discussions from patients with advanced soft tissue sarcomaNicholas Gough, Joy R Ross, Julia Riley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Biomarkers in early clinical trials: the committed and the skepticsUdai Banerji, Johann de Bono, Ian Judson, et al.
Plos One|September 27, 2019
Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcomaNicholas Gough, Jonathan Koffman, Joy R Ross, et al.
Journal of Pain and Symptom Management|January 3, 2017
Symptom Burden in Advanced Soft-Tissue SarcomaNicholas Gough, Jonathan Koffman, Joy R Ross, et al.
Cancer Biology & Therapy|March 5, 2016
p.(L576P) -KIT mutation in GIST: Favorable prognosis and sensitive to imatinib?Jonathan Noujaim, David Gonzalez, Khin Thway, et al.
Acta Oncologica (Stockholm, Sweden)|August 31, 2010
Advanced aggressive fibromatosis: Effective palliation with chemotherapyAnastasia Constantinidou, Robin L Jones, Michelle Scurr, et al.
Journal of Medical Case Reports|August 18, 2011
A patient presenting with a perivascular epithelioid cell tumor in the broad ligament: a case reportClaire Ross, Sunita Sharma, Onsy Louca, et al.
Sarcoma|December 23, 2011
Symptom burden, survival and palliative care in advanced soft tissue sarcomaNicholas J Gough, Clare Smith, Joy R Ross, et al.
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
Clinical Sarcoma Research|March 27, 2015
Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden HospitalEirini Thanopoulou, Aleksandar Aleksic, Khin Thway, et al.
Molecular Cancer Therapeutics|April 1, 2008
BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitorsUdai Banerji, Annette Affolter, Ian Judson, et al.
BMJ Supportive & Palliative Care|December 31, 2015
'<i>When something is this rare … how do you know bad really is bad…?</i>'-views on prognostic discussions from patients with advanced soft tissue sarcomaNicholas Gough, Joy R Ross, Julia Riley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Biomarkers in early clinical trials: the committed and the skepticsUdai Banerji, Johann de Bono, Ian Judson, et al.
Plos One|September 27, 2019
Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcomaNicholas Gough, Jonathan Koffman, Joy R Ross, et al.
Journal of Pain and Symptom Management|January 3, 2017
Symptom Burden in Advanced Soft-Tissue SarcomaNicholas Gough, Jonathan Koffman, Joy R Ross, et al.
Cancer Biology & Therapy|March 5, 2016
p.(L576P) -KIT mutation in GIST: Favorable prognosis and sensitive to imatinib?Jonathan Noujaim, David Gonzalez, Khin Thway, et al.
Acta Oncologica (Stockholm, Sweden)|August 31, 2010
Advanced aggressive fibromatosis: Effective palliation with chemotherapyAnastasia Constantinidou, Robin L Jones, Michelle Scurr, et al.
Journal of Medical Case Reports|August 18, 2011
A patient presenting with a perivascular epithelioid cell tumor in the broad ligament: a case reportClaire Ross, Sunita Sharma, Onsy Louca, et al.
Sarcoma|December 23, 2011
Symptom burden, survival and palliative care in advanced soft tissue sarcomaNicholas J Gough, Clare Smith, Joy R Ross, et al.
Pageof 16